Our free daily oncology focused e-news service.

Featured Oncology News

XBiotech Leaves European Meeting 'Disappointed' Over Colon Cancer Drug Rejection

(TheStreet) Apr 21, 2017 - XBiotech walked into the European Medicines Agency Thursday with a slide presentation filled with data and arguments aimed at persuading regulators there to approve the company's colon cancer drug Xilonix.

read article

Oncology Clinical News

Second Cancers Deadlier In Young Patients

(UC Davis) Apr 20, 2017 - Second cancers in children and adolescents and young adults (AYA) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers has found.

read article

New Technique Tests Therapies for Breast Cancer Metastasis

(Baylor) Apr 21, 2017 - A new laboratory technique developed by researchers at Baylor College of Medicine and other institutions can rapidly test the effectiveness of treatments for life-threatening breast cancer metastases in bone.

read article

Study Shows That Cycling to Work Could Cut Risk of Cancer by 45 Percent

(CNBC.com) Apr 20, 2017 - Research from the University of Glasgow has highlighted the benefits of cycling and walking to work.

read article

Recruitment Begins for World’s First Ovarian Cancer Vaccine Trial

(UConn) Apr 20, 2017 - UConn Health is beginning to recruit patients for the world’s first personalized genomics-driven ovarian cancer vaccine clinical trial. The goal: to prevent an often deadly relapse of the disease in women diagnosed at advanced stages.

read article

Possibility of 'Cure' for Metastatic Prostate Cancer

(Medscape Medical News) Apr 21, 2017 - Metastatic prostate cancer is considered to be incurable. But now a pilot trial, in 20 selected men with early-stage metastatic prostate cancer, has shown that aggressive multimodality treatment with hormone therapy, surgery, and radiation 'can eliminate detectable disease.'

read article (free registration required)

Elevated Liver Cancer Risk for Older Hep B-Cleared Patients

(Medscape Medical News) Apr 21, 2017 - Older people who are functionally cured of hepatitis B are at a significantly higher risk for hepatocellular carcinoma, a new study warns.

read article (free registration required)

Oncology Business and Policy News

Atara Bio Announces Collaboration with Merck to Evaluate KEYTRUDA® (pembrolizumab) in Combination with ATA129 in Nasopharyngeal Carcinoma (NPC)

(Atara Bio) Apr 21, 2017 - Atara Biotherapeutics, Inc. today announced that it has entered into a clinical trial collaboration agreement with Merck, to evaluate Atara Bio's allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTL), or ATA129, in combination with Merck's anti-PD-1 (programmed death receptor-1) therapy, KEYTRUDA® (pembrolizumab), in patients with platinum resistant or recurrent EBV-associated NPC.

read corporate press release

US Supreme Court to Consider Biosimilar Patent Process Next Week

(Regulatory Focus) Apr 20, 2017 - The highest court in the US next Wednesday will take up a fight over the so-called biosimilar "patent dance" and whether biosimilar companies have to notify reference product sponsors of the impending marketing of a new product, likely leading to a decision with ramifications for all subsequent biosimilars approved by the US Food and Drug Administration (FDA).

read article

Eight Noteworthy FDA Actions

(Healio) Apr 21, 2017 - The FDA announced several decisions related to hematology and oncology therapies and devices in the past month.

read article

Grail Initiates Massive Multicenter Breast Cancer Study

(MedCity News) Apr 20, 2017 - Illumina spin-out Grail announced a new multicenter clinical study on Thursday and, true to form, it’s a large-scale endeavor.

read article (free registration required)

H3, Foundation Medicine Extend Precision Oncology Collaboration

(Genetic Engineering & Biotechnology News) Apr 20, 2017 - Eisai subsidiary H3 Biomedicine said today it has extended its more than 2-year-old collaboration with Foundation Medicine to discover and develop precision medicines in oncology.

read article (free registration required)

Opinion: AACR’s March On Washington

(The Hill) Apr 21, 2017 - The foundation of the United States was not laid in the gloomy age of scientific drought but at an epoch when fostering innovation was better understood and more clearly defined. This is when the United States came into existence as a nation.

read article

Dying Cancer Patients Left To 'Face The Abyss Alone' Amid Nurse Shortages

(The Telegraph [UK]) Apr 21, 2017 - Women with incurable breast cancer are being abandoned to "face the abyss" alone because almost half of hospitals don't have specialist nurses, a new report warns.

read article

MD Anderson’s Jim Allison Named One of TIME’s 100 Most Influential People

(MD Anderson) Apr 20, 2017 - The University of Texas MD Anderson Cancer Center Chair of Immunology Jim Allison, Ph.D., whose pivotal insight to attack cancer by treating the immune system instead of the tumor revived cancer immunotherapy, has been named to the 2017 TIME 100.

read press release

NewYork-Presbyterian Establishes the William Rhodes and Louise Tilzer-Rhodes Center for Glioblastoma

(NewYork-Presbyterian) Apr 21, 2017 - NewYork-Presbyterian has established the William Rhodes and Louise Tilzer-Rhodes Center for Glioblastoma. Launched with an initial $5 million gift from William Rhodes, the new state-of-the-art program conducts groundbreaking research and provides cutting-edge treatments for glioblastoma and other deadly brain cancers.

read press release

Save the Dates: ASCO Quality Reporting Webinars Scheduled May 15, June 19, July 10

(ASCO in Action) Apr 18, 2017 - The Quality Payment Program (QPP), established by the Medicare Access and CHIP Reauthorization Act, launched in January 2017 and is being implemented in oncology practices across the country.

read article

Broader Healthcare and Pharma News

In the Debate Over Rising Drug Prices, Both Drugmakers And PBMs Claim Innocence

(CNBC.com) Apr 19, 2017 - The battle over rising drug prices has become a full-blown he-said-she-said. Drug companies have pointed the finger at middlemen in the health-care system, saying they not only benefit from rising drug prices but contribute to their increases.

read article

FDA Wants Researchers to Rethink Patient Eligibility Criteria

(AJMC.com) Apr 20, 2017 - Although the purpose of eligibility criteria is to protect patients from unnecessary harm, define the study population, and allow researchers to collect safety and efficacy data for a specific population, unnecessary restriction may not capture the heterogeneity of real-world patients.

read article

FDA Expands Warnings on Codeine and Tramadol for Children

(Wall Street Journal) Apr 20, 2017 - The agency says the medicines carry serious risks, including slowed breathing or death.

read article (paid subscription required)

Gene Therapy 1.0 Is a Flop, but Biotech Isn't Worried

(STAT Plus) Apr 21, 2017 - The Western world’s first gene therapy is soon to become but a footnote in biotech history, doomed by minuscule demand and a colossal price. But its failure has hardly dampened the enthusiasm of the scientists and biotech companies betting that gene therapy’s best days are ahead.

read article (paid subscription required)